Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
24.9M
-
Shares change
-
-642K
-
Total reported value, excl. options
-
$334M
-
Value change
-
-$7.76M
-
Put/Call ratio
-
0
-
Number of buys
-
38
-
Number of sells
-
-38
-
Price
-
$13.41
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2016
101 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q3 2016.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
of 37.4M outstanding shares and own 66.53% of the company stock.
Largest 10 shareholders include NWQ INVESTMENT MANAGEMENT COMPANY, LLC (3.08M shares), FRANKLIN RESOURCES INC (2.85M shares), WYNNEFIELD CAPITAL INC (2.68M shares), DIMENSIONAL FUND ADVISORS LP (2.25M shares), VANGUARD GROUP INC (1.18M shares), ARIEL INVESTMENTS, LLC (1.16M shares), ROYAL BANK OF CANADA (1.02M shares), ROYCE & ASSOCIATES LP (985K shares), HEARTLAND ADVISORS INC (964K shares), and THOMSON HORSTMANN & BRYANT INC (872K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.